Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,463,717,337
New position
Shares Held
7,421,749
first reported quarter
Ownership
0.479%
of shares outstanding
% of Portfolio
18.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 73.19426997598545.ToString("F0")%
Shared 0.ToString("F0")%
None 26.805730024014558.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CAUSEWAY CAPITAL MANAGEMENT LLC holds $1,766,978,720 across 8 Drug Manufacturers - General names. AZN ranks #1 (82.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
7,421,749 | $1,463,717,337 | |
| 2 | MRK |
Merck & Co., Inc.
|
854,212 | $102,753,161 | |
| 3 | PFE |
Pfizer Inc
|
1,914,219 | $53,751,269 | |
| 4 | BIIB |
Biogen Inc.
|
280,783 | $51,475,947 | |
| 5 | SNY |
Sanofi
|
1,064,516 | $51,288,380 | |
| 6 | NVO |
Novo Nordisk A S
|
1,174,213 | $43,152,327 | |
| 7 | GSK |
GSK plc
|
11,110 | $613,160 | |
| 8 | NVS |
Novartis AG
|
1,487 | $227,139 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,463,717,337 | 7,421,749 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||